Atopic Dermatitis, which can be seen in a wide age range from infancy to adulthood, manifests itself with dry skin and severe itching, is actually a very common chronic skin disease. It can affect the quality of life negatively due to itching that lasts for days and sleep disorders. However, the right approach and treatment can change everything. “Dermatoimmunology and Allergy Association” and “Life with Allergy Association” before 14 September Atopic Dermatitis Day; With the unconditional support of Sanofi Genzyme to raise awareness on this issue in our country, he organized a press conference and gave information about the disease.
Imagine that you are itching for more than 12 hours a day, and the accompanying insomnia, fatigue, battered skin and the consequent impact on social life. disease. However, it can be controlled with correct diagnosis and treatment, and the quality of life increases incomparably. The way to achieve this is to raise awareness about Atopic Dermatitis in the society. "Dermatoimmunology and Allergy Association" and "Life with Allergy Association", which continue to work in this direction, before September 14 Atopic Dermatitis Day; came together and shared important information about this disease that negatively affects life and makes life difficult.
"Atopic Dermatitis is not contagious and can be controlled with the right treatment"
Speaking at the meeting held with the unconditional support of Sanofi Genzyme, Dermatoimmunology and Allergy Association President Prof. Dr. Nilgün Atakan pointed out that not all eczema and Atopic Dermatitis are the same, and gave the following information: “Atopic Dermatitis is a chronic, long-lasting, recurrent, very itchy skin disease that is common at all ages but especially in childhood. Atopic Dermatitis, the prevalence of which is increasing day by day in developed societies, is a non-contagious disease with widespread eczema accompanied by severe itching, itching marks and a prominent skin dryness. The affected areas differ by age. In babies, it is mostly seen on the face, cheeks, back of the ears, neck, in children, as well as the face, arms and legs, wrists, hands and feet. In adults, it is more common on the face, neck, neck, back, hands and feet. Infections can easily develop in these eczematous areas accompanied by severe itching. The prevalence of Atopic Dermatitis in children is 20-25% on average and 20-30% of the disease that started in childhood continues in adulthood. The disease can be seen from the 5-6 months of infancy and approximately 80% of the patients are under 5 years old. Although Atopic Dermatitis is a lifelong disease in some patients; 70 percent of those starting in childhood disappear in adolescence. Atopic Dermatitis, which begins in adulthood, is seen less frequently at 2-10 percent and is more difficult to recognize due to less awareness ”.
Dermatoimmunology and Allergy Association Vice President Prof. Dr. Başak Yalçın also mentioned in her speech that Atopic Dermatitis is a disease that significantly affects both the social life of the individual and his / her family. The difficulties experienced by these patients should be fully determined and they should be given the necessary support. It is a chronic, recurrent disease that may progress with severe attacks from time to time. Severe itching causes serious sleep and concentration problems in patients and negatively affects both the social life and work and school performance of the person. Therefore, these patients should be diagnosed as soon as possible and appropriate treatment should be initiated. Thus, the disease is taken under control to a considerable extent and patients are enabled to lead a normal life.
"Patients can sometimes rely on non-scientific methods that are touted as 100 percent solutions in pursuit of hope"
Atopic Dermatitis, which is seen from infancy and can continue lifelong in some patients, not only affects the patient, but also the patient's relatives and their environment significantly. Turkey's first and only association with Life Association with Allergies allergy sufferers are also conducting studies on awareness for Atopic Dermatitis patients and patient relatives. Speaking at the meeting, Association President Özlem Ceylan stated that the biggest problem is the patient's access to diagnosis: “When we have the slightest problem, we immediately ask our relatives and they give minds like“ rub this, wash like this, use this detergent, don't worry about itching, it goes away ”and In fact, when we see the first symptoms, if we apply to a specialist and start the treatment, the deformation in the form of wounds on the skin will perhaps never occur. It is very important for patients and their relatives to accept that; this is a process, and when you start a treatment, it needs to be constantly under doctor's control. We expect the treatment to give immediate, very sudden results, and we lose our trust in the health system when the treatment time takes longer than expected. However, our acceptance that the treatment may take a long time in chronic diseases such as Atopic Dermatitis and our failure to disrupt the controls significantly affects the success of the treatment.
Özlem Ceylan, the President of Allergy and Life Association, emphasized that non-scientific products and treatments, which are found on the Internet and are touted as a 100 percent solution, and should not be trusted. “Because our health literacy as a society is not sufficient, patients sometimes fall for the pursuit of hope and methods that have not been scientifically proven. This situation can cause financial and moral damage to patients. That is why it is very important for families to be aware of this issue. It is possible to improve the quality of life of these patients with the right diagnosis and treatment in time.
About Atopic Dermatitis (Important Information)
- The prevalence of Atopic Dermatitis in children is 20 - 25 percent on average. 20 - 30 percent of the disease seen in childhood continues into adulthood.
- The disease is seen from the 5-6 months of infancy and 85% before the age of 5.
- Worldwide, 2 to 10 percent of adults are affected by Atopic Dermatitis, and 10 percent of adult patients have a severe course of the disease.
- In over 60 percent of patients with moderate to severe Atopic Dermatitis, itching lasts more than 12 hours a day.
- 46 percent of atopic dermatitis patients say their itching “often” or “always” affects their work life.
- 68 percent of adult Atopic Dermatitis patients have sleep problems. 55% of patients have sleep interruptions for more than 5 nights a week.
- Children with Severe Atopic Dermatitis experience sleep loss for at least 168 days a year.
- 14 out of every 4 children under 1 years of age with Atopic Dermatitis and 14 out of every 17 children in the 10-4 age group are exposed to negative physical or psychological effects from their environment due to their illness.
- 50 percent of adults with Atopic Dermatitis avoid social interactions because of their appearance, and 50 percent have depression and / or anxiety.
- 72 percent of patients with moderate and severe Atopic Dermatitis have accompanying allergic diseases such as asthma and allergic rhinitis.
Hibya News Agency